PHARMA-WALDHOF GMBH

Overview

PHARMA-WALDHOF GMBH is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering ADENOSINE.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances PHARMA-WALDHOF GMBH is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

PHARMA-WALDHOF GMBH holds 1 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ADENOSINEActive1988-10-25
• URIDINE-5'-TRIPHOSPHATE (UTP), THERAPEUTIC GRADEInactive1996-09-20
• N6-(2-ISOPENTENYL)-ADENOSINEInactive1990-08-17
• 5-FLUORO-URACIL,PRODUCT 4965Inactive1983-05-18
• ADENOSINE-5-MONOPHOSPHORIC ACID, PRODUCT #2030Inactive1982-05-04
• URIDINE PRODUCT #3401Inactive1982-04-23
• 5-BROMO-2' -DEOXYURIDINE (BDU)-PRODUCT NO. 6706Inactive1980-02-28
• ADENINE AND ADENINE HCL (SYNTHETIC & FROM RNA OR ADENOSINE)Inactive1978-12-20
• THYMIDINEInactive1978-06-20
• GLUTATHIONE REDUCED (GSH)Inactive1977-11-09
• GLUTATHIONE, OXIDIZED HYDRATEInactive1975-11-13

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to PHARMA-WALDHOF GMBH in our records. PharmaTek screens the full directory against live FDA enforcement data.